ELI LILLY AND CO. v. TEVA PHARMACEUTICALS USA

Nos. 2010-1005, 2010-1033.

619 F.3d 1329 (2010)

ELI LILLY AND COMPANY, Plaintiff-Cross Appellant, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant.

United States Court of Appeals, Federal Circuit.

September 1, 2010.


Attorney(s) appearing for the Case

Charles E. Lipsey , Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, of Reston, VA, argued for plaintiff-cross appellant. With him on the brief were L. Scott Burwell ; David S. Forman , Howard W. Levine , Laura P. Masurovsky , Mark J. Feldstein , and J. Derek McCorquindale , of Washington, DC. Of counsel on the brief was Gilbert T. Voy , Eli Lilly and Company, of Indianapolis, IN.

Edward H. Rice , Loeb & Loeb LLP, of Chicago, IL, argued for defendant-appellant. With him on the brief were Marina N. Saito , Steven M. Lubezny and Julie P. Samuels .

Before RADER, Chief Judge, LINN and PROST, Circuit Judges.


RADER, Chief Judge.

Following an 11-day bench trial, defendant Teva Pharmaceuticals USA, Inc. ("Teva") appeals the district court's permanent injunction preventing any manufacture or distribution of a generic version of the drug Evista® until the expiration of U.S. Patent Nos. 6,906,086 (the "'086 patent"); RE39,049 (the "'049 patent"); RE38,968 (the "'968 patent") (collectively the "Bone Loss Patents"); and RE39,050...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases